Clear Capital Markets is engaged to market the companies featured below. This is a financial promotion.
A pre-IPO group building proprietary applications inside the World ecosystemco-founded by Sam Altman.
It offers UK investors a regulated entrypoint ahead of admission to AIM, in a category where retail access at this stage is rare.
A UK-listed medical AI company developing clinical decision-support tools for healthcare providers.
A recently announced supply agreement with Eli Lilly puts the business inside oneof the largest pharmaceutical supply chains in the world.
A pre-IPO group building proprietary applications inside the World ecosystem co-founded by Sam Altman.
It offers UK investors a regulated entrypoint ahead of admission to AIM, in acategory where retail access at thisstage is rare.
The following warning applies to the pre-IPO opportunities above (Humanity One):
Don't invest unless you're prepared to lose all the money you invest. These are high-risk investments. They can behard to sell, their value can go down as well as up, and you are unlikely to be protected if something goes wrong. Take 2 minutes to learn more.
The companies named above are mentioned for informational purposes. This is not a recommendation to buy, sell or hold. The market value of these instruments can fall as well as rise. Past performance is not a guide to future performance.
Our offices are based in the heart of the City of London where we offer a warm welcome to both existing and potential clients.
We are open from 7 am to 7 pm from Monday to Friday.
To arrange a face to face meeting or to make an enquiry please get in contact by telephone or email
Clear Capital Markets does not hold clients' funds or assets. Client money and assets are held with our custodians James Brealey and Sons Ltd and GHC Capital Markets Ltd.
https://www.jbrearley.co.uk/All investments carry risk. The value of shares and the income from them may go down as well as up and you may not get back the money you invested. Past performance is not a reliable indicator of future results.
Investments in Small Cap Shares involve a high degree of risk and are not suitable for all investors. Companies listed on the AIM or Aquis market can be highly volatile and are considered high risk speculative investments.
